Clinical trials recruiting in Ingolstadt, Germany

Phase breakdown

Conditions recruiting in Ingolstadt, Germany

Recruiting trials in Ingolstadt, Germany

• BAROSTIM THERAPY™ In Resistant Hypertension
  NCT02880631 · Phase: Not specified · Ages: No age limits stated · Sex: All (male and female)
• BAROSTIM THERAPY™ in Heart Failure With Reduced Ejection Fraction
  NCT02880618 · Phase: Not specified · Ages: No age limits stated · Sex: All (male and female)
• Comparison of LAA-Closure vs Oral Anticoagulation in Patients With NVAF and Status Post Intracranial Bleeding.
  NCT04298723 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female)
• Maintenance ElectroConvulsive Therapy in Clozapine RESISTant Schizophrenia - the MECT-RESIST Trial
  NCT06456983 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 75 Years · Sex: All (male and female)
• Post-resection/Ablation Chemotherapy in Patients With Metastatic Colorectal Cancer (FIRE-9 - PORT / AIO-KRK-0418)
  NCT05008809 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• Study to Assess Real Life Effectiveness of Foslevodopa/Foscarbidopa in Adult German Participants at Initial Stages of Advanced Parkinson's Disease (EARLY-FOS)
  NCT06916507 · Phase: Not specified · Ages: 18 Years to 64 Years · Sex: All (male and female)

Common questions

How many clinical trials are recruiting in Ingolstadt, Germany?

6 recruiting trials have at least one study site in Ingolstadt, Germany.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.